| 호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 로빈 매튜 홀레트; 파트리샤 앤 깁린; 잔느 마그람 et al. (2021). Combination of LIF inhibitors and platinum-based anti-neoplastic agents for use in treating cancer. Patent Number: KR20210022065A. |
|
Patent |
|
| 호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 로빈 매튜 홀레트; 피터 에드워드 베일리스; 아지타 제가나탄 et al. (2021). Methods for improving response to anti-LIF antibody treatment in a subject with cancer. Patent Number: KR20210024007A. |
|
Patent |
|
| ãã£ãªãã ãªã³ã³ãã«ãã¸ã§ã¤ã ãº; Philip O'connell James; ãã£ãªãã ãªã³ã³ãã«ãã¸ã§ã¤ã ãº; ããã¼ã ãã¼ã¿ã¼ãã¸ã§ã³; Robert Porter John et al. (2021). New TNFα structure for therapeutic use. Patent Number: JP2021109880A. |
|
Patent |
|
| Andreas Ernst; Sachdev Sidhu; Linda Beatty (2021). Specific active site inhibitors of enzymes or substrate binding partners and methods of producing same. Patent Number: CA3053192C. |
|
Patent |
|
| Anish SURI; Steven Sheriff; Suzanne Suchard; Aaron YAMNIUK; Stanley Krystek et al. (2021). Methods of treating immune diseases by administering antibody polypeptides that antagonize CD40. Patent Number: US11136406B2. |
|
Patent |
|
| Attar Ricardo; D Powers Gordon; Gaudet Francois; Pillarisetti Kodandaram; Thomas Baldwin Eric et al. (2021). BCMA Antibodies, BCMA and CD3 Bispecific Antigen-Binding Molecules, and Their Uses. Patent Number: JO3799B1. |
|
Patent |
|
| Cathleen M. Crudden; J. Hugh Horton; Mina Raafat Ryad Narouz; Joseph Daniel Padmos (2021). Methods of forming carbene-functionalized composite materials. Patent Number: US11008291B2. |
|
Patent |
|
| Dorothea KOMINOS; Jie Zhang; Alla Pritsker; Matthew Davison; Nicolas Baurin et al. (2021). Antibodies to bradykinin b1 receptor ligands. Patent Number: MY184037A. |
|
Patent |
|
| Edward Sargent; Cao-Thang DINH; Francisco PELAYO GARCIA DE ARQUER; Alexander IP (2021). Composite multilayered electrocatalysts for co2 reduction and associated methods. Patent Number: EP3571331B1. |
|
Patent |
|
| Edward Sargent; Phil DE LUNA; Fanglin CHE; Yansong ZHOU (2021). Boron-doped copper catalysts for efficient conversion of co2 to multi-carbon hydrocarbons and associated methods. Patent Number: EP3784819A1. |
|
Patent |
|
| Folgueira Judit Anido; Patricia Anne Giblin; Robin Matthew Hallett; Jeanne Magram; Naimish Pandya et al. (2021). COMBINATION OF LIF INHIBITORS AND PLATINUM-BASED ANTI-NEOPLASICS AGENTS FOR USE IN THE TREATMENT OF CANCER. Patent Number: MA52300A. |
|
Patent |
|
| Folgueira Judit Anido; Peter Edward Bayliss; Teixidor Ester Bonfill; Patricia Anne Giblin; Robin Matthew Hallett et al. (2021). PROCEDURES FOR IMPROVING THE RESPONSE TO ANTI-BODY TREATMENT ANTI-LIF IN INDIVIDUALS WITH CANCER. Patent Number: MA52299A. |
|
Patent |
|
| Folgueira Judit Anido; Teixidor Ester Bonfill; Johan Fransson; Garcia Monica Pascual; Rigol Ester Planas et al. (2021). COMBINATION OF LIF INHIBITORS AND PD-1 AXIS INHIBITORS FOR USE IN THE TREATMENT OF CANCER. Patent Number: MA52231A. |
|
Patent |
|
| Guo Shuaiqi; Voets Ilja; Davies Peter; Klose Karl (2021). Peptides for use in the treatment of cholera. Patent Number: NL2023527B1. |
|
Patent |
|
| Hedda WARDEMANN; Rajagopal MURUGAN; Tizian DECKER; Elena Levashina; Guilia COSTA et al. (2021). Plasmodium antibodies. Patent Number: WO2021001351A1. |
|
Patent |
|